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Alternatives to conventional enterocystoplasty have been developed in order to avoid the
most common complications derived from contact of the urine with intestinal mucosa.
In this article critically we review the literature on the topics: ureterocystoplasty, detru-
sorectomy, detrusorotomy, seromuscular gastroenterocystoplasty, use of off the shelf
biomaterials, and bladder augmentation by bioengineering. Recognizing the difficulty of
deciding when a child with a history of posterior urethral valves requires and augmenta-
tion and that the development of a large megaureter in cases of neurogenic dysfunction
represents a failure of initial treatment, we conclude that ureterocystoplasty can be useful
in selected cases when a large dilated ureter is available. Seromuscular colocystoplasty
lined with urothelium (SCLU) has been urodynamically effective in several series when
the outlet resistance is high and no additional intravesical procedures are necessary. Sero-
muscular gastrocystoplasty lined with urothelium seems to offer no distinct advantages
and involves a much more involved operation. The use of seromuscular segments with-
out urothelial preservation, with or without the use of an intravesical balloon has been
reported as successful in two centers but strict urodynamic evidence of its effectiveness
is lacking. The published evidence argues strongly against the use of detrusorectomy or
detrusorotomy alone because of the lack of significant urodynamic benefits. Two recent
reports discourage the use of small intestinal submucosa patches because of a high failure
rate. Finally, research into the development of a bioengineered bladder constructed with
cell harvested from the same patient continues but is fraught with technical and conceptual
problems. In conclusion of the methods reviewed, only ureterocystoplasty and SCLU have
been proven urodynamically effective and reproducible.
Keywords: ureterocystoplasty, seromuscular colocystoplasty, autoaugmentation, enterocystoplasty, bioengi-
neered bladder, detrusorectomy, detrusorotomy
Normal bladder capacity (BC) and compliance are essential to
maintain normal renal function and allow urinary continence.
The most frequent causes of reduced functional or anatomical BC
in children are neurogenic dysfunction (NVD), posterior urethral
valves (PUVs), and bladder exstrophy (BE). When more conserv-
ative methods (1) such as medications or injection of Botulinum
toxin fail, surgical bladder augmentation is needed to achieve
continence and prevent or correct hydronephrosis.
The use of reconfigured intestinal segments to increase blad-
der volume is effective (2, 3) but not without side effects (4,
5). Bringing urine in contact with functioning ileal or colonic
mucosa can cause metabolic acidosis and intestinal mucus secre-
tion into the urinary bladder may lead to difficult emptying
and bladder lithiasis. Perforation of the augmented bladder
can be a life threatening complication. The risk of malignancy
development has been of concern to many but appears to be
<5% (6).
Abbreviations: BC, bladder capacity; BE, Bladder exstrophy; NVD, neurovesical
dysfunction; PUVs, posterior urethral valves, SCLU, seromuscular colocystoplasty
lined with urothelium.
Almost three decades ago, gastrocystoplasty was developed in
hopes to obviate some of these problems (7, 8). Unfortunately the
use of stomach had to be all but abandoned because of undesirable
outcomes and side effects (3) in many patients (9).
Many researchers have explored alternatives to conventional
enterocystoplasty. These include ureterocystoplasty (10), detru-
sorotomy and detrusorectomy (11), seromuscular enterocysto-
plasty with or without preservation of the urothelium (12, 13), the
use of biomaterials (14) and most recently, attempts to construct
a bioengineered bladder with cultured cells (15).
Although many very innovative and creative procedures have
been reported some reports lack rigorous analysis of urody-
namic data before and after the procedure. The degree of
augmentation should be determined by comparing pre- and
post-operative pressure specific BC or safe BC (16) and when
appropriate, expected safe capacity for age. Here we report
our analysis of the urodynamic outcomes of alternative proce-
dures to conventional enterocystoplasty published in the liter-
ature in order to guide practicing surgeons as to the appro-
priate indications and expected results of the various available
techniques.
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MATERIALS AND METHODS
We reviewed the literature (PubMed) under the headings blad-
der augmentation, ureterocystoplasty, enterocystoplasty, autoaug-
mentation, non-secretory cystoplasty, and bioengineered blad-
der. Articles containing pertinent information were selected and
when available, full text articles reviewed. Articles reporting post-
operative BC are cited but only those reporting pre- and post-
operative pressure specific BC (16) and age specific BC are dis-
cussed in detail. Series selected for this report comprised largely
pediatric populations. Case reports are cited if they report on
important technical innovation.
RESULTS
URETEROCYSTOPLASTY
The use of a dilated ureter to enlarge the bladder was first described
by Eckstein and Martin (10) but no reports followed until 1993
when the separate reports of Bellinger (17) and Churchill et al.
(18) awakened widespread interest in this technique. The reasons
for this interest are clear since the ureter is lined with urothelium
avoiding the side effects related to urine being in contact with
intestinal or gastric mucosa. All conceivable variations of urete-
rocystoplasty have been described including the use of the entire
ureter and removal of the ipsilateral kidney (19), using only the
distal ureter on one side and reimplanting the proximal ureter in
the bladder (20), constructing a transureteroureterostomy (21), or
using both distal ureters (22). The use of lower ureter of a com-
pletely duplicated in conjunction with a lower pole nephrectomy
has been also reported (23). Peroviç et al. dilated the ureter distal to
a loop ureterostomy prior to using it to augment the bladder (24).
Hitchcock et al. (21) reported urodynamic results in eight chil-
dren (PUV4; BE2; NVD2) in seven of whom the ureterocystoplasty
was done with a segment of one dilated distal ureter with preserva-
tion of the kidney and a transureteroureterostomy. BC increased
from 100 ml (mean, range 45–215) to 311 ml (mean, range 150–
450) a statistically significant difference. Pre- and post-operative
bladder pressures decreased in all cases to safe values. This report
was followed by a report from Miami (25) of five cases in which a
variety of techniques were used resulting in a pressure specific BC
increase from 142 ml (mean) to 500 ml.
Landau et al. (26) compared the results of ureterocystoplasty
(eight children) and ileocystoplasty (eight children) and found a
small difference in the degree of increased BC between the groups
favoring ureterocystoplasty. In contrast, Podesta conducted a sim-
ilar study and found ileocystoplasty to produce a greater degree
of augmentation than ureterocystoplasty (27) but in both reports
the results of uretero and ileocystoplasty were similar. A retrospec-
tive study of a larger series from two centers was reported in 1999
(28). Thirty-two patients had ureterocystoplasty either with the
entire ureter of a one or two non-functioning kidneys or with a
segment of dilated distal ureter the proximal end of which was
then anastomosed to the contralateral ureter. The authors found
no significant differences between the use of one or two ureters
but reported a greater increase in pressure specific BC when the
entire ureter was used (median increase in BC 3.75-fold) and a
lesser increase when a segment of distal ureter was used (mean
increase 230%). Unfortunately absolute BC in one group was not
reported.
Husmann et al. (29) conducted a retrospective multicenter
study including 64 patients operated with various techniques. The
majority of the patients (71%) had NVD. They concluded that in
patients with non-refluxing megaureters with an ultrasonographic
diameter ≥1.5 cm had universal success when the entire ureter
was used for the augmentation. In contrast, those with refluxing
megaureters only did well if the compliance of the system was nor-
mal or only mildly decreased. In this series, the group of patients
in whom a dilated distal ureter was used resulted in poor augmen-
tation and the need to re-augment the bladder was 92%. This is in
sharp contrast with the success rate reported in 22 patients using
a segment of dilated distal ureter and by Pascual et al. (30). I n this
series pressure specific BC increased from a mean of 105–254 ml
(2.4-fold) with an improvement in the mean compliance from
10 to 24 ml/cm H2O. Half of the patients reached the expected
capacity for age but one suffered a spontaneous perforation and
underwent enterocystoplasty. The degree of augmentation is com-
parable to other series (see Table 1). Other reports already dis-
cussed had also obtained acceptable results using a segment of
distal ureter (21, 28).
In response to the report of Husmann at al. (29), Johal et al. (31)
analyzed the results in 17 children followed for a mean of 4.5 years.
The series was different from Husmann et al.’s in that only two
children had NVD. Nine underwent augmentation with a distal
dilated ureter and preservation of the kidney. Overall success was
seen in 76% of the patients and four required enterocystoplasty.
Many others have documented an acceptable success rate with
various forms of ureterocystoplasty (32–36).
Table 1 summarizes the results of 10 publications reporting
pressure specific BC.
DETRUSORECTOMY/DETRUSOROTOMY
In 1953 Couvelaire proposed removing part of the detrusor leaving
the urothelium intact as a means of increasing BC in tuberculous
cystitis (11) and called the procedure bladder decortication. The
concept of incising or removing part of the pathological detrusor
to allow the more normal urothelium to expand and thus increase
BC was described again by Cartwright and Snow (37). They
called the procedure “bladder autoaugmentation.” The reported
degree of augmentation confirmed in pre- and post-operative
urodynamics studies after either detrusorectomy or detrusoro-
tomy has been modest at best (38–44) (Table 2) and some reports
showed a decrease in BC after the operation in almost 1/3 of
the cases (45). In an experimental canine model of reduced BC,
Garibay et al. reported no increase in BC 6 months after partial
detrusorectomy (46).
Hansen et al. (47) reported long term results of detrusorec-
tomy in 25 children with NVD followed for a mean of 6.8 years.
BC was defined as “maximum tolerated bladder filling or volume
at leakage.” Pressure specific BC was not reported. Mean maximal
BC decreased in the first few months from 130 to 96 but increased
progressively after 1 year to a mean of 176 ml in 19 of 25 patients.
This represents an increase of 1.35-fold assuming that the mean
BC for the 19 patients was the same as that of the entire group.
Age specific expected BC was not reported. Compliance increased
in the first 5 years of follow up in many patients. Of interest is
that leak pressure decreased sharply in five children who had no
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Table 1 | Summary of results of ureterocystoplasty in publications that listed pressure specific BC.
Reference Number of cases Mean age
(year)
PUV NVD BE Other Whole
ureter
Distal
ureter
Fold increase in
pressure specific BC
Churchill et al. (18) 16 8.8 1 12 1 2 15 1 Unknown
4 (With intra-operative
ureteral occlusion)
2.84
Hitchcock et al. (21) 8 8.5 4 2 2 1 7 3
Gosalbez and Kim (25) 7 14 2 3 7 3.5
Zubieta et al. (28) 32 9 7 20 5 19 13 3.75a
2.30b
Peroviç et al. (24) 16 6.6 8 8 8 3
Pascual et al. (30) 22 7.2 22 22 2.4
Husmann et al. (29) 64 Not stated 18 46 40 24 6 (Single non-refluxing
ureter ≥1.5 cm)
1.6 (Single refluxing ureter)
All others failed
Podestá et al. (27) 8 6 1 5 8 1.83
Johal et al. (31) 17 5.9 10 2 3 2 7 9 2.3
Kajbafzadeh et al. (32) 13 7.3 7 7 2
aWhole ureter.
bDistal ureter.
FU, mean follow up period; PUVs, posterior urethral valves, NVD, neurogenic bladder dysfunction; BE, bladder exstrophy, BC bladder capacity.
Table 2 | Summary of results of detrusorectomy or detrusorotomy in publications that listed pressure specific BC.
Reference Number of
cases
Mean age
(year)
PUV NVD BE Other Fold increase in
pressure specific BC
Comments
Stothers et al. (38) 12 4–14 1 10 1 0.4 Detrusorotomy
Carr et al. (44) 8 1.96 Peritoneal flaps
Oge et al. (39) 13 11.9 11 2 0.61 Detrusorectomy and peritoneal flap
MacNeily et al. (40) 17 10.2 17 1.4 71% Considered clinical failures
Lindley et al. (41) 11 10 11 1.3 Detrusorectomy covered with omentum
or peritoneal flap
Rocha et al. (42). Group 1 8 12 7 0 Detrusorectomy
Rocha et al. (42). Group 2 10 8.5 10 1.7 Detrusorectomy and silicone balloon for
2 weeks
Veenboer et al. (43) 26 15 26 1.26 Detrusorectomy
Hansen et al. (47) 25 9 25 1.35 Pressure or age specific BC not reported
Total 130 Mean 1.05
PUVs, posterior urethral valves; NVD, neurogenic bladder dysfunction; BE, bladder exstrophy; BC, bladder capacity.
additional bladder neck procedures. Table 2 summarized the series
published.
Chrzan et al. (48) recently reported 49 patients with NVD in
whom the preoperative expected BC for age was mean 98% (mean,
range 35–153%). After detrusorectomy BC rose to 108% (15–
156%). They authors claimed“good and fair”success in 39/49 cases
(79.6%). Unfortunately raw urodynamic data were not reported
making the interpretation of the data difficult. They do not explain
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why the operation was done in patients with normal or greater
than normal BC. In the view of the authors the fact that 11 of 49
patients (22%) were able stop taking antimuscarinic medications
seemed to justify the use of this procedure.
An interesting technical variation of detrusorectomy was
reported by Rocha et al. (42). This group performed detrusorec-
tomy in 22 children, in 12 in whom the standard technique was
used, no urodynamic benefit was appreciated. In contrast, in the
10 children in whom an intravesical silicon balloon filled with
50–100 ml of fluid was left indwelling for 2 weeks, the expected
BC for age increased from a mean of 46–82%. Regrettably, again,
actual BCs for this group was children were omitted from the table
published.
COVERED DETRUSORECTOMY
Disappointment with the results of detrusorectomy and detru-
sorotomy, which is likely due to the development of fibrosis around
the denuded urothelium and regrowth of abnormal detrusor mus-
cle (40, 46), led many to develop techniques to prevent fibrosis and
preserve BC and compliance. Peritoneal flaps, omentum, rectus
muscle, the seromuscular layer of the colon or the stomach have
been used with varying success.
Although in the usual course of a detrusorectomy performed
extraperitoneally the denuded urothelium ends up covered with
the parietal peritoneum that normally covers the cephalad half of
the bladder, Oge et al. (39) created a peritoneal flap to cover the
urothelium and obtained only minimal improvement (Table 2).
Carr et al. also covered the urothelium with peritoneal flaps with
variable clinical results (44). Likewise, Lindley et al. obtained min-
imal augmentation effect covering the (41) denuded urothelium
with omentum in 11 patients (Table 2). Peroviç et al. (49) covered
the urothelium with rectus abdominis muscle flaps in seven chil-
dren and reported a 2.27-fold increase in BC but unfortunately
the definition of BC employed is not given.
SEROMUSCULAR COLOCYSTOPLASTY LINED WITH UROTHELIUM
In 1995 two independent groups from USA and Brazil published
clinical series of an operation consisting of a detrusorectomy
covered by a reconfigured seromuscular segment of left colon
(12, 13). The US group called this procedure seromuscular colo-
cystoplasty lined with urothelium (SCLU) and the Brazilian group
used the term non-secretory sigmoid cystoplasty. The main dif-
ference among the techniques lies in the method to remove the
colonic mucosa. Whereas the US technique preserved the colonic
submucosa, the other removed it in an effort to prevent colonic
secretory cells regrowth. Table 3 shows results of eight series pub-
lished by four different groups of investigators who reported pre-
and post-operative urodynamic data. The authors of these reports
are from US, Europe, Turkey, and Korea. In all 147 patients have
been reported with an average 2.64-fold increase in BC. González
et al. (50) reported that success with this technique depends on
being able to maintain the bladder distended for the first post-
operative week to allow coaptation of the urothelium to the
seromuscular sigmoid segment. They recommended keeping the
pressure inside the bladder at about 20 cm H2O. This necessi-
tates a water tight bladder mucosa. In this authors’ view, this fact
limits the possibility of performing concomitant procedures that
violate the urothelium such as appendicovesicostomy or uretero-
neocystostomy. They reported universal success when there was no
post-operative urine leak. In contrast, three of five patients who
underwent a simultaneous appendicovesicostomy, had prolonged
urinary leaks and failed. An experimental study indicated that the
preserved urothelium in SCLU behaves normally regarding the
absorption of ammonia (51).
Also the procedure works best in patients with high out-
let resistance to prevent early urine leak around the catheter,
for example those who have an artificial urinary sphincter
or a sling implanted prior or at the time of the augmenta-
tion (52). Preoperative measures of leak point pressure are no
always reliable as the detrusorectomy can cause a drop in outlet
resistance (38).
SEROMUSCULAR GASTROCYSTOPLASTY LINED WITH UROTHELIUM
Instead of using the seromuscular layer of the colon, other authors
have used the gastric wall from which the mucosa and submucosa
had been removed in small clinical series. Unfortunately none of
Table 3 | Summary of results of seromuscular colocystoplasty line with urothelium in publications that listed pressure specific BC.
Reference Number of cases Mean age (year) NVD PUV Fold increase in BC
Gonzalez et al. (12) 16 11.7 14 2 2.4
Lima et al. (13) 10 10.4 9 2.49 Did not measure safe BC but maximal BC
Dewan (78) 6 6 2.9
Dayanç et al. (76) 10 13 10 3.8
Jednak et al. (66) 28 11.1 28 2.4
González et al. (52) 27 11 27 2.36 All had AUS
González et al. (50) 16 9 16 1.83 Without concomitant bladder procedures
Jung et al. (77) 34 10 2.96
Total 147 2.64
PUVs, posterior urethral valves; NVD, neurogenic bladder dysfunction; BE, bladder exstrophy; BC, bladder capacity.
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the published series report pre- and post-operative pressure spe-
cific BC. Dewan and Stefanek (53) reported on seven patients
in whom the BC increased 5.9-fold. Nguyen at al. (54) reported
seven patients with an increased in BC of 2.16-fold and Carr et al.
(44) reported on 10 patients with urodynamic data in whom BC
increased 1.85. There have been no reports on the clinical use of
this operation in the last 14 years.
SEROMUSCULAR ENTEROCYSTOPLASTY WITHOUT UROTHELIAL
PRESERVATION
To avoid the sometimes tedious dissection necessary to separate the
detrusor from the bladder urothelium when constructing a sero-
muscular augmentation lined with urothelium, Lima proposed
opening the bladder in its full thickness as for a conventional ente-
rocystoplasty and then augmenting it with a segment of colon (55)
or ileum (56) from which the mucosa and submucosa had been
removed. To prevent contraction of the intestinal patch, a silicon
balloon was left in the bladder for 2 weeks. The first series reported
using colon included 24 patients half of which were older than
10 years. The authors report an increase in BC of more than four-
fold, however the data are difficult to interpret since the method
to determine BC is not described and before the operation 21/24
had a capacity <100 ml of which three had 0 ml BC. These low val-
ues are seldom encountered in practice and in other publications.
Another criticism of this publication is that the series included
three children <4 years of age. The justification for doing an aug-
mentation at such early age is not given. In the eight patients in
whom the ileum was used, BC increased an average of 2.9-fold.
Regrettably the method of measuring BC (i.e., pressure specific or
maximal) was not specified in either of these reports. The same
group published a summary of their experience with these tech-
niques in 2008 (57). In a total of 173 patients with urodynamic
data, 23 failed. In the remaining patients mean increase in capac-
ity was threefold. The same shortcomings described for the 1998
paper are also present in this publication.
Like Lima, de Badiola et al. (58) also omitted preservation of
the urothelium, did not find the use of a balloon necessary in 10
children and coagulated the sigmoid mucosa with the argon coag-
ulator before removal to prevent regrowth. At a mean follow up
of 18 months, they reported an increase in BC of 3.75-fold. The
method used to determine BC is not reported. No other centers
have reported results of these procedures.
PATCHES OF BIOMATERIALS
The idea of using a readily available off the shelf material has
attracted investigators for decades. Only few clinical studies have
been reported. Arikan et al. (14) reported the use of Dura matter
in 10 patients with NVD to augment the bladder, which had been
previously used experimentally by Kelâmi (59). They reported a
2.3-fold increase in BC but the follow up period was not men-
tioned. Caione et al. (60) used small intestinal submucosa (SIS) in
five children after closure of BE and obtained a negligible increase
in BC. Likewise Schaefer et al. (61) failed to obtain good results
in five patients with a variety of diagnosis using SIS to en large
the bladder. SIS had been used experimentally with encouraging
results (62) which is just one example of the difficulty of moving
from animal experimentation to the clinic.
BIOENGINEERED BLADDER
Experimental efforts to construct a tissue engineered bladder with
a scaffold seeded with cultured cells previously obtained from the
bladder to be augmented have been reported for 15 years (63, 64)
and culminated with a report of its clinical application in seven
patients with myelomeningocele (15). At the time of that report
the mean follow up was 46 months. At 25–36 months of follow up
BC decreased in one patient and there was a mild increase in three
(1.04-, 1.24-, and 1.5-fold). At 49–61 months of follow up, four
patients had urodynamic studies. Increase in BC was 1.56-, 1.02-,
1.53-, and 3.45-fold. Pressure specific BC was not reported and the
compliance in this apparently successful case was only 10.2 ml/cm
H2O and the bladder pressure 47 cm H2O. At last follow up the
only patient with acceptable compliance (18 ml/cm H2O) was one
who had a preoperative BC of 438 ml. No further clinical reports
of this procedure have been published.
DISCUSSION
The objective results of any procedure used to augment BC should
be measured urodynamically. Symptomatic results are difficult to
interpret given the variable reporting practices regarding urinary
continence. Neurologically impaired patients often have altered
bladder sensation and detrusor sphincter dyssynergia or non-
relaxing bladder outlet. In this population, measurement of BC
based on patient’s desire to void or leak point (65) should be
avoided. Instead, safe or pressure specific pressure should be used
(16). Significant differences between maximal BC and safe BC
have been reported (66). This should be taking into consideration
when interpreting results of procedures since it often leads to an
overoptimistic interpretation.
It should be kept in mind that the purpose of bladder aug-
mentation is to provide a capacious, low pressure reservoir to
maintain renal integrity and allow the patient to be dry emptying
the bladder periodically by intermittent catheterization. Spon-
taneous voiding after bladder augmentation can be achieved in
neurologically intact patients but it is the exception rather than
the rule.
In this review we have included some series that reported total
BC but have pointed out this potential shortcoming. In uncon-
trolled studies with long follow up in children it is difficult to
differentiate the benefits from the procedure and the normal
growth in BC.
URETEROCYSTOPLASTY
From this review it is clear that patients needing a bladder aug-
mentation who have a significantly dilated ureter can benefit from
ureterocystoplasty. The operation can be done transperitoneally
or retroperitoneally through one or two incisions or laparoscopic
assisted (67). The papers reviewed present divergent opinions
regarding the use of a segment of distal ureter versus the entire
ureter. Of course, the latter is only possible when the kidney does
not function and can be removed. One of the problems of most
reports is that the preoperative urodynamic evaluation in patients
with massive reflux can be difficult to interpret. Podesta et al. (27)
used video-urodynamics in an attempt to attribute volumes and
pressures to the bladder versus the ureters. Churchill et al. (18) and
subsequently Gosalbez and Kim (25) occluded refluxing ureters
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intraoperatively to measure BC independently from the volume
that refluxed into the ureters.
The finding by Husmann et al. (29) that in patients with reflux-
ing ureters the results are good only when the compliance of
the system (bladder plus refluxing ureters) is normal or mildly
decreased raises the question whether the augmentation in those
patients was really needed. Probably in such cases, only by occlud-
ing the ureters during the urodynamic investigation can the proper
indication for augmentation be made. This method has the limita-
tions of a study performed under general anesthesia. The question
is particularly valid for most children with a history of PUV and
massive uni or bilateral reflux. Furthermore, in PUV patients,
BC and compliance tend to increase with age, particularly when
there is associated polyuria. In general the indications for bladder
augmentation are not clearly defined. A bladder that may have
inadequate capacity in a polyuric child with renal failure may be
perfectly adequate after renal transplantation when the daily urine
output normalizes (68).
The situation is quite different in patients with NVD. In
this patient population, good care from the onset should pre-
vent hydronephrosis and the development of massive ureteral
dilatation. Some authors have reported acceptable results in such
patients but is should be kept in mind that the development of a
useful megaureter in children with NVD should be an exceptional
occurrence (32).
In order to expand the application of ureterocystoplasty,
researchers have progressively dilated normal ureters in experi-
mental animals hoping to make them useful for bladder augmen-
tation but clinical application’s have not been reported (69, 70).
In conclusion, ureterocystoplasty can be useful in selected
patients; however, in the most common condition in childhood
needing bladder augmentation, namely NVD, it should rarely be
an option. In the case of children with a history of PUV, a con-
dition frequently associated with megaureters, the indications for
bladder augmentation are often unclear (68).
DETRUSORECTOMY/DETRUSOROTOMY
Although the term auto augmentation has become widely accepted
it should be abandoned. In Greek autós means self or spontaneous
and augmentation implies increase or enlargement, therefore the
meaning of either term does not apply to the operations more cor-
rectly termed detrusorotomy or partial detrusorectomy. Although
a few groups around the world continue to perform these opera-
tions, the degree of urodynamic augmentation reported by most
is minimal or non-existing raising serious doubts about the justi-
fication of its use (40, 41, 47, 71, 72). In our opinion, the fact that
in one report a handful of children stopped taking anticholinergic
medications (48) does not justify the operation. The idea of keep-
ing the bladder distended after the detrusorectomy with a balloon
as has been reported for other forms of cystoplasty (see below)
is intriguing and hopefully it will be further explored by Rocha
et al. (42) and reported with more valid urodynamic data. From
the literature reviewed it is apparent that covering the urothelium
with peritoneal flaps or omentum does not improve outcomes
significantly. The small series from Belgrade (24) in which the
urothelium was covered with rectus muscle flaps is interesting but
has not been reproduced by others and a larger series with longer
follow up has not been reported.
SEROMUSCULAR ENTEROCYSTOPLASTY
The concept of a detrusorectomy covered with a segment of intes-
tine without mucosa to create an in vivo bioengineered bladder
seems to have been developed simultaneously in the US (12) and
Brazil (13). Dewan and Stefanek in Australia used a segment of the
stomach without mucosa for the same purpose in four patients
(53). The same authors published a case report of seromuscular
augmentation colocystoplasty preserving the urothelium in a sin-
gle patient (73). It is interesting that this patient was operated on
and reported despite unfavorable results of this procedure in a
sheep model obtained by the same authors on the same year (74).
In contrast, both the US and the Brazilian authors performed the
procedure in patients after successful experimentation in canine
models (13, 75). The results of SCLU, the operation described by
González et al. (12) have been reproduced by surgeons in Turkey
(76), Korea (77), and Australia (78). Bandi et al., independently
of the surgeon who performed the procedure, compared 26 cases
of SCLU with 32 of conventional enterocystoplasty and found
a comparable degree of bladder augmentation. In all 147 cases
have been reported and the degree increase in safe BC was 2.6-
fold. One of the limitations of this operation is that it requires
to maintain the bladder distended for 1 week after surgery to
allow coaptation of the urothelium to the seromuscular colonic
segment. This implies having high outlet resistance by prior or
simultaneous implantation of an artificial sphincter or a sling in
patients with NVD since high leak point pressures may change
after detrusorectomy (38, 47). It is also desirable to avoid post-
operative urine leaks (50). The use of a gastric segment to cover the
denuded epithelium seems to offer no advantages over the colon
and has the potential for increased morbidity. Thus it cannot be
recommended.
There is a difference of opinion as to whether the submucosa
of the colon should be left in place. Both Lima et al. (79) and
Dewan et al. (80) recommended removing it to prevent regrowth
of colonic epithelium, but Buson el al. (75) argued that remov-
ing the submucosa leaves an unsatisfactory bowel segment for
augmentation.
To avoid the spending the time and effort necessary to per-
form a satisfactory detrusorectomy leaving the urothelium intact,
Lima et al. (79) and de Badiola et al. (58) used the demucosalized
bowel as in a conventional cystoplasty, that is without preserv-
ing the urothelium. To prevent contraction of the segment, Lima
et al. left an intravesical silicone balloon indwelling for 2 weeks.
The reported results of their series did not include changes in
safe BC and the procedure has not been reported from other cen-
ters. Likewise, the removal of the intestinal mucosa with the argon
coagulator has not been reported by other groups (58).
PATCHES OF BIOMATERIALS
Despite promising initial results with the use of a lyophilized patch
of Dura matter by one author (14), no other reports have followed.
Clinical results with the use of SIS suggest that this operation
should not be done (60, 61).
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BIOENGINEERED BLADDER
The creation of a suitable graft composed of a scaffold lined with
cultured urothelial cell inside and detrusor myocytes outside than
can then be implanted in a patient to augment the bladder is a
feat of tissue engineering which has potential clinical applications.
It would be unquestionably of benefit to have large amounts of
cultured urothelium from a given patient to apply as a lining to
a flap of tissue capable of improving BC and compliance. Such
approach, using cultured urothelium and a seromuscular colonic
segment has been used experimentally (81). However, a construct
of detrusor myocytes grafted into a patient with abnormal bladder
innervation is doomed to fail since if it were re-innervated it
would end up with the same problems as the original bladder.
Furthermore inducing re-vascularization and re-innervation of
such constructs has been problematic. An excellent review on the
subject has recently been published (82).
CONCLUSION
This review suggests that the only alternatives to enterocystoplasty
for which there is some evidence of urodynamic effectiveness
are ureterocystoplasty and SCLU. Both techniques require good
patient selection and are applicable to only some of the patients
requiring enterocystoplasty. It is to be hoped that further research
in this field will produce other alternative in the future.
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